Adam S. Walpert1, Ian D. Thomas2, Merlin C. Lowe Jr1, Michael D. Seckeler3
Congenital Heart Disease, Vol.13, No.3, pp. 428-431, 2018, DOI:10.1111/chd.12590
Abstract Objective: The aim of this study was to compare inpatient outcomes and costs for children with
respiratory syncytial virus and congenital heart disease before and after the change in management
guidelines for respiratory syncytial virus prophylaxis.
Design: Hospital discharge data from the Vizient (formerly University HealthSystem Consortium)
were queried from October 2012 to June 2014 (Era 1) and July 2014 to April 2016 (Era 2) for
patients aged <24 months with an any International Classification of Disease (ICD)-9 or ICD-10
code for congenital heart disease (745-747.49, Q20.0-Q26.4) and a primary or secondary admitting diagnosis of respiratory syncytial virus infection (079.6,… More >
Login
Register
